Cefmetazole
From Wikipedia, the free encyclopedia
|
Cefmetazole
|
|
| Systematic (IUPAC) name | |
| (6R,7S)-7-{[2-(cyanomethylsulfanyl)acetyl]amino}- 7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]- 8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C15H17N7O5S3 |
| Mol. mass | 471.538 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Cefmetazole is a cephalosporin.
Side Effects - The N-methyl-thiotetrazole side chain causes many bleeding problems and disulfaram-like reactions with substances such as alcohol.
|
||||||||||||||||||||

